Literature DB >> 19842114

A tissue-like construct of human bone marrow MSCs composite scaffold support in vivo ectopic bone formation.

D Ben-David1, T Kizhner, E Livne, S Srouji.   

Abstract

Biocompatible and osteoconductive cell-scaffold constructs comprise the first and most important step towards successful in vivo bone repair. This study reports on a new cell-scaffold construct composed of gelatin-based hydrogel and ceramic (CaCO(3)/beta-TCP) particles loaded with human MSCs producing a tissue-like construct applied as a transplant for in vivo bone formation. Bone marrow-derived human MSCs were cultured in osteogenic induction medium. 5 x 10(5) (P(2)) cells were loaded on a mixture of hydrogel microspheres and ceramic particles, cultured in a rotating dynamic culture for up to 3 weeks. Both hydrogel microspheres and ceramic particles coalesced together to form a tissue-like construct, shown by histology to contain elongated spindle-like cells forming the new tissue between the individual particles. Cell proliferation and cell viability were confirmed by Alamar blue assay and by staining with CFDA, respectively. FACS analysis conducted before loading the cells, and after formation of the construct, revealed that the profile of cell surface markers remained unchanged throughout the dynamic culture. The osteogenic potential of the cells composing the tissue-like construct was further validated by subcutaneous transplants in athymic nude mice. After 8 weeks a substantial amount of new bone formation was observed in the cell-construct transplants, whereas no bone formation was observed in transplants containing no cells. This new cell construct provides a system for in vivo bone transplants. It can be tailored for a specific size and shape as needed for various transplant sites and for all aspects of regenerative medicine and biomaterial science. 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 19842114     DOI: 10.1002/term.213

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  8 in total

Review 1.  Brief review of models of ectopic bone formation.

Authors:  Michelle A Scott; Benjamin Levi; Asal Askarinam; Alan Nguyen; Todd Rackohn; Kang Ting; Chia Soo; Aaron W James
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

2.  Comparison of TGFbR2 down-regulation in expanded HSCs on MBA/DBM scaffolds coated by UCB stromal cells.

Authors:  Zahra Sadat Hashemi; Mehdi Forouzandeh Moghadam; Masoud Soleimani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-12-25       Impact factor: 2.416

Review 3.  Biomimetic Approaches for Bone Tissue Engineering.

Authors:  Johnathan Ng; Kara Spiller; Jonathan Bernhard; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part B Rev       Date:  2017-01-18       Impact factor: 6.389

4.  The emerging role of mesenchymal stem cells in tissue engineering.

Authors:  Ali Dehghanifard; Mohammad Shahjahani; Masoud Soleimani; Najmaldin Saki
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

5.  An update on the Application of Nanotechnology in Bone Tissue Engineering.

Authors:  M F Griffin; D M Kalaskar; A Seifalian; P E Butler
Journal:  Open Orthop J       Date:  2016-12-30

6.  Micro-Computed-Tomography-Guided Analysis of In Vitro Structural Modifications in Two Types of 45S5 Bioactive Glass Based Scaffolds.

Authors:  Fabian Westhauser; Francesca Ciraldo; Preethi Balasubramanian; Anne-Sophie Senger; Gerhard Schmidmaier; Arash Moghaddam; Aldo R Boccaccini
Journal:  Materials (Basel)       Date:  2017-11-23       Impact factor: 3.623

7.  Calcium Chelidonate: Semi-Synthesis, Crystallography, and Osteoinductive Activity In Vitro and In Vivo.

Authors:  Elena Avdeeva; Ekaterina Porokhova; Igor Khlusov; Tatyana Rybalova; Elvira Shults; Larisa Litvinova; Valeria Shupletsova; Olga Khaziakhmatova; Irina Sukhodolo; Mikhail Belousov
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-17

8.  A combined cell and growth factor delivery for the repair of a critical size tibia defect using biodegradable hydrogel implants.

Authors:  Talia Cohen; Olga Kossover; Eli Peled; Tova Bick; Lena Hasanov; Tan Tuan Chun; Simon Cool; Dina Lewinson; Dror Seliktar
Journal:  J Tissue Eng Regen Med       Date:  2022-02-04       Impact factor: 4.323

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.